HC Wainwright & Co. Reiterates Buy on NovaBridge Biosciences, Maintains $9 Price Target

Benzinga · 3d ago
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates NovaBridge Biosciences (NASDAQ:NBP) with a Buy and maintains $9 price target.